Medicinal benefits of the mushroom Ganoderma.

Publisher Summary This chapter discusses medicinal benefits of the Mushroom Ganoderma . Recently, the fruit body and liquid-cultured mycelium of Ganoderma have been reported to contain polysaccharides which inhibit the growth of tumors. Identified as glucans, one of the major constituents in the cell wall of fungi, they appear to increase bodily resistance against the growth of tumors, induce the production of interferon, enhance the immunity function, and kill tumor cells within the body. The role of medicinal mushrooms in metabolic regulation is gaining greater attention. Their use in the development and application of beneficial biological activities offers an advantage in that the active principle is safe and can be tolerated by humans. Cultivation of such mushrooms provides an adequate supply but is unnecessary if mycelial cultures grown in large-scale fermentations can produce the same active principle. Finally, the search for new uses for the traditional medicinal fungi continues and the public should be educated about their potential value.

[1]  T. Furuya,et al.  Ganoderic acid derivatives, highly oxygenated lanostane-type triterpenoids, from Ganoderma lucidum , 1986 .

[2]  Y. Kimura,et al.  Effects of the extracts of Ganoderma lucidum on blood glucose level in rats. , 1988, Planta medica.

[3]  V. Tertov,et al.  Antiatherogenic and antiatherosclerotic effects of mushroom extracts revealed in human aortic intima cell culture , 1989 .

[4]  K. Yamasaki,et al.  Structures of New Terpenoid Constituents of Ganoderma lucidum (Fr.) KARST (Polyporaceae) , 1985 .

[5]  S. Kimura,et al.  Dietary effect of Ganoderma lucidum mushroom on blood pressure and lipid levels in spontaneously hypertensive rats (SHR). , 1988, Journal of nutritional science and vitaminology.

[6]  L. Shuzhen,et al.  Some pharmacological actions of the spores of Ganoderma lucidum and the mycelium of Guanoderma capense (Lloyd) Teng cultivated by submerged fermentation. , 1979, Chinese medical journal.

[7]  R. Whistler,et al.  Noncytotoxic, antitumor polysaccharides. , 1976, Advances in carbohydrate chemistry and biochemistry.

[8]  T. Nishitoba,et al.  Novel Triterpenoids and a Steroid from the Fungus Ganoderma lucidum , 1988 .

[9]  M. Shiro,et al.  A ganoderic acid derivative, a highly oxygenated lanostane-type triterpenoid from Ganoderma lucidum , 1985 .

[10]  T. Nishitoba,et al.  Bitter triterpenoids from the fungus Ganoderma applanatum , 1989 .

[11]  T. Nishitoba,et al.  Novel Triterpenoids from the Fungus Ganoderma lucidum , 1988 .

[12]  T. Nishitoba,et al.  New Terpenoids, Ganoderic Acid J and Ganolucidic Acid C, from the Fungus Ganoderma lucidum , 1985 .

[13]  K. Tsubono,et al.  Constituents of the Fungus Ganoderma lucidum (FR.) KARST. III. : Structures of Ganolucidic Acids A and B, New Lanostane-Type Triterpenoids , 1986 .

[14]  M. Shiao,et al.  Triterpenes in Ganoderma lucidum , 1988 .

[15]  M. Shiro,et al.  Ganoderic acid derivatives and ergosta-4,7,22-triene-3,6-dione from Ganoderma lucidum ☆ , 1987 .

[16]  M. Shiao,et al.  Triterpenes from Ganoderma lucidum , 1988 .

[17]  G. Ourisson,et al.  Les acides ganoderiques tàz : triterpenes cytotoxiques de Ganoderma lucidum (Polyporacée) , 1983 .

[18]  T. Nishitoba,et al.  Ganoderiol A and B, new triterpenoids from the fungus Ganoderma lucidum (Reishi) , 1986 .

[19]  I. Miura,et al.  Structures of Ganoderic Acid A and B, Two New Lanostane Type Bitter Triterpenes from Ganoderma lucidum (FR.) KARST. , 1982 .

[20]  M. Arakawa,et al.  Isolation and characterization of antitumor active β-D-glucans from the fruit bodies of Ganoderma applanatum , 1983 .

[21]  M. Shiao,et al.  Two New Triterpenes of the Fungus Ganoderma lucidum , 1987 .

[22]  T. Ikekawa,et al.  Antitumor polysaccharides from some polyporaceae, Ganoderma applanatum (Pers.) Pat and Phellinus linteus (Berk. et Curt) Aoshima. , 1971, Chemical and pharmaceutical bulletin.

[23]  H. Maruyama,et al.  Antitumor activity of Sarcodon aspratus (Berk.) S. Ito and Ganoderma lucidum (Fr.) Karst. , 1989, Journal of pharmacobio-dynamics.

[24]  H. Hikino,et al.  Mechanisms of hypoglycemic activity of ganoderan B: a glycan of Ganoderma lucidum fruit bodies. , 1989, Planta medica.

[25]  H. Tokuda,et al.  Malonate half-esters of homolanostanoid from an asian Ganoderma fungus , 1990 .

[26]  C. Hara,et al.  Polysaccharides in fungi. XIII. Antitumor activity of various polysaccharides isolated from Dictyophora indusiata, Ganoderma japonicum, Cordyceps cicadae, Auricularia auricula-judae, and Auricularia species. , 1983, Chemical & pharmaceutical bulletin.

[27]  T. Mizuno,et al.  Hypoglycemic actions of some heteroglycans of Ganoderma lucidum fruit bodies. , 1989, Planta medica.

[28]  H. Hikino,et al.  Glycan structures of ganoderans b and c, hypoglycemic glycans of ganoderma lucidum fruit bodies , 1986 .

[29]  Y. Umeda,et al.  Effect of Polysaccharides from Ganoderma applanatum on Immune Responses , 1979, Microbiology and immunology.

[30]  S. Tanaka,et al.  Complete amino acid sequence of an immunomodulatory protein, ling zhi-8 (LZ-8). An immunomodulator from a fungus, Ganoderma lucidium, having similarity to immunoglobulin variable regions. , 1989, The Journal of biological chemistry.

[31]  S. Kadota,et al.  GANODERIC ACID D, E, F, AND H AND LUCIDENIC ACID D, E, AND F, NEW TRITERPENOIDS FROM GANODERMA LUCIDUM , 1985 .

[32]  T. Miyazaki,et al.  Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum. , 1981, Chemical & pharmaceutical bulletin.

[33]  T. Nishitoba,et al.  New Terpenoids, Ganolucidic Acid D, Ganoderic Acid L, Lucidone C and Lucidenic Acid G, from the Fungus Ganoderma lucidum , 1986 .

[34]  K. Yamasaki,et al.  The biologically active constituents of Ganoderma lucidum (Fr.) Karst. Histamine release-inhibitory triterpenes. , 1985, Chemical & pharmaceutical bulletin.

[35]  T. Hayashi,et al.  Three new lanostanoids from Ganoderma lucidum. , 1986, Journal of natural products.

[36]  K. Chung,et al.  Studies on the antineoplastic components of Korean basidiomycetes , 1980 .

[37]  T. Miyazaki,et al.  Structural examination of an alkali-extracted, water-soluble heteroglycan of the fungus Ganoderma lucidum , 1982 .

[38]  N. Ikekawa,et al.  Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum. , 1986, Chemical & pharmaceutical bulletin.

[39]  Y. Inada,et al.  Isolation of an inhibitor of platelet aggregation from a fungus, Ganoderma lucidum. , 1985, Chemical & pharmaceutical bulletin.

[40]  M. Shimizu,et al.  Ganoderic acid and its derivatives as cholesterol synthesis inhibitors. , 1989, Chemical & pharmaceutical bulletin.

[41]  C. Hara,et al.  Polysaccharides in fungi. XIV. Anti-inflammatory effect of the polysaccharides from the fruit bodies of several fungi. , 1983, Journal of pharmacobio-dynamics.

[42]  K. Tsubono,et al.  Constituents of the Fungus Ganoderma lucidum (FR.) KARST. II. : Structures of Ganoderic Acids F, G, and H, Lucidenic Acids D2 and E2, and Related Compounds , 1986 .

[43]  K. Tsubono,et al.  Constitutents of the Fungus Ganoderma lucidum (FR.) KARST. I. : Structures of Ganoderic Acids C2, E, I, and K, Lucidenic Acid F and Related Compounds , 1986 .

[44]  M. Shiro,et al.  GANODERIC ACIDS T, S AND R, NEW TRITERPENOIDS FROM THE CULTURED MYCELIA OF GANODERMA LUCIDUM , 1986 .

[45]  T. Nishitoba,et al.  Triterpenoids from the fungus Ganoderma lucidum , 1987 .

[46]  H. Hikino,et al.  Isolation and hypoglycemic activity of ganoderans A and B, glycans of Ganoderma lucidum fruit bodies. , 1985, Planta medica.

[47]  M. Arakawa,et al.  Antitumor Activity of Water-Soluble β-D-Glucan Elaborated by Ganoderm applanatum , 1981 .

[48]  T. Furuya,et al.  Changes of the triterpenoid patterns during formation of the fruit body in Ganoderma lucidum , 1990 .

[49]  Y. Sone,et al.  Structures and Antitumor Activities of the Polysaccharides Isolated from Fruiting Body and the Growing Culture of Mycelium of Ganoderma lucidum , 1985 .

[50]  J. Watanabe,et al.  Isolation and characterization of a new immunomodulatory protein, ling zhi-8 (LZ-8), from Ganoderma lucidium. , 1989, The Journal of biological chemistry.

[51]  S. Jong,et al.  Antitumor and antiviral substances from fungi. , 1989, Advances in applied microbiology.

[52]  T. Nishitoba,et al.  New Terpenoids from Ganoderma lucidum and Their Bitterness , 1985 .